Nautilus Biotechnology, Inc. (NAUT) earnings
NAUT earnings moved a median of -0.72% by the close. Quarterly and annual NAUT reports and results, each read against the price at its own news timestamp. Back to the NAUT overview →
30 measured NAUT earnings events.
Where these NAUT earnings landedvs 30 measured NAUT earnings reactions
| Middle 50% of NAUT earnings reactions | -3.89% to +4.15% |
|---|---|
| Median reaction (to close) | -0.72% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 NAUT earnings events with a measured close landed between -3.89% and +4.15%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026 | Press release | +0.97% | +4.35% | |
| Form 10-Q Nautilus Biotechnology, For: Jun 30 | SEC filing · Form 10-Q | -0.26% | -14.05% | |
| Nautilus Biotechnology Reports Second Quarter 2026 Financial Results | Press release | -12.50% | -25.00% | |
| Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 | Press release | +1.18% | +5.33% | |
| Form 10-Q Nautilus Biotechnology, For: Mar 31 | SEC filing · Form 10-Q | +1.94% | -3.10% | |
| Nautilus Biotechnology Reports First Quarter 2026 Financial Results | Press release | -2.53% | -6.50% | |
| Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 | Press release | +4.47% | -2.88% | |
| Form 10-K Nautilus Biotechnology, For: Dec 31 | SEC filing · Form 10-K | +1.24% | +0.00% | |
| Form 10-Q Nautilus Biotechnology, For: Sep 30 | SEC filing · Form 10-Q | -0.70% | -0.70% | |
| Nautilus Biotechnology Reports Third Quarter 2025 Financial Results | Press release | +5.93% | +5.93% | |
| Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 | Press release | +2.27% | -1.59% | |
| Form 10-Q Nautilus Biotechnology, For: Jun 30 | SEC filing · Form 10-Q | +2.23% | -0.74% | |
| Nautilus Biotechnology Reports Second Quarter 2025 Financial Results | Press release | +0.14% | -4.87% | |
| Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025 | Press release | +4.18% | -5.94% | |
| Form 10-Q Nautilus Biotechnology, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -3.01% | |
| Nautilus Biotechnology Reports First Quarter 2025 Financial Results | Press release | +2.14% | +4.89% | |
| Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 | Press release | +0.00% | -6.44% | |
| Form 10-K Nautilus Biotechnology, For: Dec 31 | SEC filing · Form 10-K | +10.91% | +10.17% | |
| Form 10-Q Nautilus Biotechnology, For: Sep 30 | SEC filing · Form 10-Q | -0.36% | -5.69% | |
| Nautilus Biotechnology Reports Third Quarter 2024 Financial Results | Press release | +6.34% | +3.36% | |
| Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 | Press release | +1.87% | +0.75% | |
| Form 10-Q Nautilus Biotechnology, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +3.04% | |
| Nautilus Biotechnology Reports Second Quarter 2024 Financial Results | Press release | +0.00% | -2.56% | |
| Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 | Press release | +0.00% | -0.88% | |
| Form 10-Q Nautilus Biotechnology, For: Mar 31 | SEC filing · Form 10-Q | -2.32% | +7.34% | |
| Nautilus Biotechnology Reports First Quarter 2024 Financial Results | Press release | -0.76% | -4.15% | |
| Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 | Press release | +0.39% | +3.54% | |
| Form 10-K Nautilus Biotechnology, For: Dec 31 | SEC filing · Form 10-K | +4.64% | +0.00% | |
| Form 10-Q Nautilus Biotechnology, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +4.49% | |
| Nautilus Biotechnology Reports Third Quarter 2023 Financial Results | Press release | +0.00% | +8.94% |
Keep exploring
More NAUT: analyst actions → · SEC filings → · NAUT overview →